Will Congress Scuttle the AbbVie-Shire Merger?

AbbVie's $54.8 billion proposal to acquire Irish drug maker Shire would mark the largest tax inversion ever, as a growing number of U.S. companies pursue lower rates overseas.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.